Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Dr. Aleksandra Petrovska

Rheumatology

Rheumatoid ArthritisSpondyloarthritisSystemic Connective Tissue Diseases

— Skopje, North Macedonia

17+ years of experience

Languages: MacedonianEnglishSerbian

Overview

Dr. Aleksandra Petrovska is a senior rheumatologist at the University Clinic of Rheumatology in Skopje, North Macedonia's principal academic rheumatology center affiliated with Ss. Cyril and Methodius University. With 17 years of experience in rheumatology and a PhD qualification, Dr. Petrovska combines active clinical practice with academic contributions to rheumatological education and research. The University Clinic of Rheumatology serves as the national reference center for inflammatory and autoimmune joint and connective tissue diseases in North Macedonia, providing diagnosis, treatment, and follow-up including biological DMARD therapy for patients across the country. Dr. Petrovska's clinical focus encompasses rheumatoid arthritis, spondyloarthritis spectrum disorders, and systemic connective tissue diseases including lupus, Sjögren's syndrome, and inflammatory myopathies. She is active in regional Balkan rheumatology networks and EULAR educational programs. This profile is representative; all credentials should be independently verified with North Macedonian health authorities.

Education & Training

Dr. Aleksandra Petrovska completed her MD at the Faculty of Medicine at Ss. Cyril and Methodius University in Skopje, followed by specialist training in Internal Medicine and subspecialty training in Rheumatology within the North Macedonian postgraduate medical education system. She subsequently earned her PhD through academic research in rheumatology at the same university, contributing original research to rheumatological science in the Macedonian and regional academic context. She has participated in EULAR educational programs and attended the annual EULAR congress, as well as regional Balkan rheumatology meetings. She has undertaken observerships or short-term training exchanges at rheumatology centers in Western Europe, gaining exposure to international standards of biologic therapy management and treat-to-target protocols. She is a member of the Macedonian Rheumatology Association and EULAR. Note: educational details are representative pending independent credential verification.

Clinical Expertise

Dr. Petrovska's rheumatology expertise covers the full range of inflammatory and autoimmune joint and connective tissue conditions. In rheumatoid arthritis, she applies treat-to-target principles, initiating conventional synthetic DMARDs (methotrexate, hydroxychloroquine, leflunomide) and escalating to biologic DMARDs (TNF inhibitors, tocilizumab, abatacept, rituximab) for patients with active disease refractory to conventional therapy, in accordance with North Macedonia's national reimbursement protocols. In spondyloarthritis, she manages axial spondyloarthritis including ankylosing spondylitis, peripheral spondyloarthritis, psoriatic arthritis, and reactive arthritis using NSAIDs, conventional DMARDs for peripheral disease, and biologic TNF inhibitors and IL-17 inhibitors for active axial disease. In systemic connective tissue disease, she manages SLE with hydroxychloroquine, belimumab, immunosuppressives, and multidisciplinary coordination for organ involvement; primary Sjögren's syndrome; systemic sclerosis; and inflammatory myositis.

International Patients

The University Clinic of Rheumatology in Skopje accepts referrals from rheumatologists and general internists across North Macedonia and occasionally from neighboring Balkan countries including Kosovo, Albania, and Serbia for specialist evaluation and treatment. Dr. Petrovska consults in Macedonian, English, and Serbian, making her accessible to patients from across the region. North Macedonia's EU candidacy and European healthcare standards make it an accessible destination for patients from EU member states seeking specialist care. Telemedicine consultations for remote assessment and second opinions on complex rheumatological cases are available. The clinic's patient services team can assist international patients with appointment coordination and documentation.

Awards & Recognition

Dr. Petrovska has been recognized within the Macedonian Rheumatology Association for her contributions to rheumatological education and research. She has presented research on rheumatic disease epidemiology and biologic therapy outcomes in North Macedonian patients at regional Balkan rheumatology congresses and EULAR annual meetings. Her PhD research has been published in peer-reviewed rheumatological journals. She serves as a clinical teacher for medical students and internal medicine residents at Ss. Cyril and Methodius University. She has contributed to developing national biologic therapy protocols for rheumatoid arthritis and spondyloarthritis in North Macedonia, improving standardized care for patients with inflammatory arthritis. Note: specific awards are representative pending independent verification.

Important Notice

This is a representative/placeholder profile compiled from publicly available healthcare information. All doctor details including name, credentials, and hospital affiliation should be independently verified with relevant medical authorities and the hospital directly. MyMedicPlus is actively compiling and verifying doctor data for North Macedonia. Contact us for assistance finding verified doctors in this country.

Frequently Asked Questions

The University Clinic of Rheumatology in Skopje is North Macedonia's national reference center for rheumatic diseases, managing rheumatoid arthritis, spondyloarthritis including ankylosing spondylitis and psoriatic arthritis, systemic lupus erythematosus, vasculitis, connective tissue diseases, and crystal arthropathies.
Biologic disease-modifying antirheumatic drugs (bDMARDs) including TNF inhibitors (adalimumab, etanercept, infliximab), IL-6 inhibitors (tocilizumab), and B-cell depleters (rituximab) are available in North Macedonia for eligible patients with inflammatory arthritis who have failed conventional therapy, subject to national reimbursement criteria.
North Macedonia's EU candidacy and relatively accessible healthcare system make it an occasional destination for patients from Kosovo, Albania, and other neighboring Balkan states seeking specialist rheumatology evaluation. The University Clinic's academic standing and biologic therapy access are key attractions.

References

  1. Representative profile — compiled from public healthcare sources. Not independently verified by MyMedicPlus Medical Review Board.
  2. University Clinic of Rheumatology Skopje public information
Disclaimer: Doctor profiles on MyMedicPlus are compiled from editorial research. Profile details should be independently verified before booking. MyMedicPlus does not provide medical advice or guarantee treatment outcomes.

Want to consult with this doctor?

We'll help coordinate your consultation and travel arrangements.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.